(19)
(11) EP 4 580 665 A2

(12)

(88) Date of publication A3:
16.05.2024

(43) Date of publication:
09.07.2025 Bulletin 2025/28

(21) Application number: 23861597.5

(22) Date of filing: 01.09.2023
(51) International Patent Classification (IPC): 
A61K 39/02(2006.01)
C07K 14/20(2006.01)
A61P 31/04(2006.01)
C07K 16/12(2006.01)
(52) Cooperative Patent Classification (CPC):
Y02A 50/30; A61K 39/0225; A61P 31/04; C07K 14/20
(86) International application number:
PCT/US2023/073311
(87) International publication number:
WO 2024/050512 (07.03.2024 Gazette 2024/10)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 02.09.2022 US 202263403451 P
11.05.2023 US 202363501445 P

(71) Applicant: The Medical College of Wisconsin, Inc.
Milwaukee, WI 53226 (US)

(72) Inventors:
  • LOCHHEAD, Robert B.
    Germantown, Wisconsin 53022 (US)
  • DANNER, Rebecca L.
    Milwaukee, Wisconsin 53207 (US)
  • ROUSE, Joseph R.
    Milwaukee, Wisconsin 53221 (US)
  • PROCHNIAK, Lauren
    Kenosha, Wisconsin 53142 (US)

(74) Representative: J A Kemp LLP 
80 Turnmill Street
London EC1M 5QU
London EC1M 5QU (GB)

   


(54) USE OF IMMUNOGENIC T CELL EPITOPES FOR LYME DISEASE VACCINATION AND DIAGNOSIS